Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors

NCT03070301

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

NCT03507491

Conditions
Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +33 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Chilldren's Healthcare of Atlanta Atlanta, Georgia, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
View Trial Details
Completed

A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

NCT03875079

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Iowa Iowa City, Iowa, United States
  • Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

NCT03936465

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, Pediatric, +26 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions